Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Antoch

Showing results (191-200 of 443) with videos related to

Pageof 45
Sort By:
Journal of Magnetic Resonance Imaging : JMRI|June 8, 2013
Direct comparison of intra-articular versus intravenous delayed gadolinium-enhanced MRI of hip joint cartilageChristoph Zilkens, Falk Miese, Young-Jo Kim, et al.
European Journal of Radiology|June 3, 2020
Impact of different iterative metal artifact reduction (iMAR) algorithms on PET/CT attenuation correction after port implementationOle Martin, Johannes Boos, Joel Aissa, et al.
Magma (New York, N.Y.)|February 27, 2014
Pilot study of Iopamidol-based quantitative pH imaging on a clinical 3T MR scannerAnja Müller-Lutz, Nadia Khalil, Benjamin Schmitt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2004
Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumorsGerald Antoch, Jörg Kanja, Sebastian Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PETGerald Antoch, Nina Saoudi, Hilmar Kuehl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 25, 2007
TNM staging with FDG-PET/CT in patients with primary head and neck cancerPatrick Veit-Haibach, Christopher Luczak, Isabel Wanke, et al.
European Journal of Radiology|February 23, 2013
Diffusion-weighted imaging as part of hybrid PET/MRI protocols for whole-body cancer staging: does it benefit lesion detection?Christian Buchbender, Verena Hartung-Knemeyer, Karsten Beiderwellen, et al.
Journal of Cancer Research and Clinical Oncology|May 28, 2015
The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomyChristian Arsov, Nikolaus Becker, Robert Rabenalt, et al.
Radiology|September 27, 2003
Non-small cell lung cancer: dual-modality PET/CT in preoperative stagingGerald Antoch, Jörg Stattaus, Andre T Nemat, et al.
European Radiology|May 6, 2009
Gastrointestinal 18F-FDG accumulation on PET without a corresponding CT abnormality is not an early indicator of cancer developmentTill A Heusner, Steffen Hahn, Monia E Hamami, et al.
Pageof 45

Showing results (191-200 of 443) with videos related to

Sort By:
Pageof 45
Journal of Magnetic Resonance Imaging : JMRI|June 8, 2013
Direct comparison of intra-articular versus intravenous delayed gadolinium-enhanced MRI of hip joint cartilageChristoph Zilkens, Falk Miese, Young-Jo Kim, et al.
European Journal of Radiology|June 3, 2020
Impact of different iterative metal artifact reduction (iMAR) algorithms on PET/CT attenuation correction after port implementationOle Martin, Johannes Boos, Joel Aissa, et al.
Magma (New York, N.Y.)|February 27, 2014
Pilot study of Iopamidol-based quantitative pH imaging on a clinical 3T MR scannerAnja Müller-Lutz, Nadia Khalil, Benjamin Schmitt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2004
Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumorsGerald Antoch, Jörg Kanja, Sebastian Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PETGerald Antoch, Nina Saoudi, Hilmar Kuehl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 25, 2007
TNM staging with FDG-PET/CT in patients with primary head and neck cancerPatrick Veit-Haibach, Christopher Luczak, Isabel Wanke, et al.
European Journal of Radiology|February 23, 2013
Diffusion-weighted imaging as part of hybrid PET/MRI protocols for whole-body cancer staging: does it benefit lesion detection?Christian Buchbender, Verena Hartung-Knemeyer, Karsten Beiderwellen, et al.
Journal of Cancer Research and Clinical Oncology|May 28, 2015
The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomyChristian Arsov, Nikolaus Becker, Robert Rabenalt, et al.
Radiology|September 27, 2003
Non-small cell lung cancer: dual-modality PET/CT in preoperative stagingGerald Antoch, Jörg Stattaus, Andre T Nemat, et al.
European Radiology|May 6, 2009
Gastrointestinal 18F-FDG accumulation on PET without a corresponding CT abnormality is not an early indicator of cancer developmentTill A Heusner, Steffen Hahn, Monia E Hamami, et al.
Pageof 45